| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/10/2002 | WO2000055370A3 Bar coding and indentifying nucleic acids using a limited number of probes and low stringency conditions |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004938 Models of prion disease |
| 01/10/2002 | US20020004937 Method for detecting an aberrant animal-derived prion gene and a prion gene modified mouse which exhibits heart anomalies |
| 01/10/2002 | US20020004592 Method for amplifying full length single strand polynucleotide sequences |
| 01/10/2002 | US20020004589 Detecting sensitivity to kidney disease |
| 01/10/2002 | US20020004585 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 01/10/2002 | US20020004581 Polypeptide; for use in te diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004239 Nucleotide sequences coding genetically engineered polypeptide; for use in the treatment of mammary gland cancer |
| 01/10/2002 | US20020004230 Broth for biosynthesis of deoxyribonucleic acids |
| 01/10/2002 | US20020004227 Nucleotide sequences coding immunoglobulins; for use in treating cancer |
| 01/10/2002 | US20020004220 Dosing and development of antimicrobial and antiviral drugs determined by restriction of resistant mutant selection |
| 01/10/2002 | US20020004219 Diagnosis of bacteria infections |
| 01/10/2002 | US20020004218 Bone disorders therapy |
| 01/10/2002 | US20020004214 Detecting modulators of enzymatic activity; mix modulator, kinase and phosphate source, incubate and isolate enzyme, monitor enzyme for adjustment in enzymatic activity |
| 01/10/2002 | US20020004213 Quantitative analysis; cancer diagnosis |
| 01/10/2002 | US20020004211 Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes |
| 01/10/2002 | US20020004206 Methods of screening for disease |
| 01/10/2002 | US20020004204 Apparatus for use in the detection and analysis of preferential nucleotide sequences |
| 01/10/2002 | US20020004203 Reduced activity of polymerase chain reactions |
| 01/10/2002 | US20020004202 In vivo screen using chemical inducers of dimerization |
| 01/10/2002 | US20020004201 Methods for the detection of loss of heterozygosity |
| 01/10/2002 | US20020004199 No wash bead assay, kit and procedure |
| 01/10/2002 | US20020004197 Method for generating a pathway reporter system |
| 01/10/2002 | US20020004052 Composition comprising a tumor cell extract and method of using the composition |
| 01/10/2002 | US20020004047 DNA encoding a novel RG1 polypeptide |
| 01/10/2002 | US20020004043 Cellular and animal models for diseases associated with altered mitochondrial function |
| 01/10/2002 | US20020004040 Complementary adenoviral vector systems and cell lines |
| 01/10/2002 | DE10065626A1 Einzelmolekül-Sequenzierungsverfahren Single-molecule sequencing method |
| 01/10/2002 | DE10031932A1 Calpain-Protease 12 Calpain protease 12 |
| 01/10/2002 | DE10030827A1 Verfahren zum Nachweis von Cathepsinen, Asparaginylendopeptidase und deren Isozyme, sowie von Leukocystatin A method for the detection of cathepsins, asparaginyl endopeptidase and their isozymes, as well as of Leukocystatin |
| 01/10/2002 | CA2416292A1 Transgenic mice containing targeted gene disruptions |
| 01/10/2002 | CA2415258A1 Devices and methods for carrying out chemical reactions using photogenerated reagents |
| 01/10/2002 | CA2415125A1 Polynucleotide sequence assay |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | CA2414995A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | CA2414672A1 Novel human serine-threonine kinase |
| 01/10/2002 | CA2414626A1 A method for extracting quantitative information relating to interactions between cellular components |
| 01/10/2002 | CA2414596A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | CA2414594A1 Process for the measurement of dinophysistoxin and of yessotoxin |
| 01/10/2002 | CA2414592A1 Calpain protease 12 |
| 01/10/2002 | CA2414497A1 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 01/10/2002 | CA2414375A1 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 01/10/2002 | CA2413756A1 Dna encoding human serine protease d-g |
| 01/10/2002 | CA2413753A1 Antifungal compounds and methods of use |
| 01/10/2002 | CA2413715A1 Grf2-binding proteins and applications thereof |
| 01/10/2002 | CA2413427A1 Multiplex sequencing method |
| 01/10/2002 | CA2413262A1 B7-like molecules and uses thereof |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413158A1 Ecm-related tumor marker |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412973A1 Sequencing method and apparatus |
| 01/10/2002 | CA2412946A1 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 01/10/2002 | CA2412925A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2412292A1 Base analogues |
| 01/10/2002 | CA2411794A1 Signal amplification with lollipop probes |
| 01/10/2002 | CA2410953A1 Adenylyl and guanylyl cyclases |
| 01/10/2002 | CA2410679A1 Secretion and trafficking molecules |
| 01/10/2002 | CA2408829A1 Regulated gene expression in yeast and methods of use |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | CA2406643A1 Natural promoters for gene expression and metabolic monitoring in bacillus species |
| 01/10/2002 | CA2383194A1 Methylene blue diagnostic agent and diagnostic methods for detection of epithelial cancer |
| 01/09/2002 | EP1170594A2 Methods for the identification of compounds useful for the treatment of disease states mediated by Prostaglandin D2 |
| 01/09/2002 | EP1170592A1 Presentation of hydrophobic antigens to T-cells by CD1 molecules |
| 01/09/2002 | EP1170591A2 Methods for identifying combinations of entities as therapeutics |
| 01/09/2002 | EP1170589A1 Method for histocompatibility testing |
| 01/09/2002 | EP1170383A2 Oligonucleotides and method for detection of small round structured virus (SRSV) RNA |
| 01/09/2002 | EP1170381A2 Method for the non-specific amplification of nucleic acid |
| 01/09/2002 | EP1170380A2 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 01/09/2002 | EP1170379A1 Sample generation for genotyping by mass spectrometry |
| 01/09/2002 | EP1170378A1 Method for monitoring the effect of cancer therapies |
| 01/09/2002 | EP1170377A2 Method for identifying inhibitors of protoporphyrinogen oxidase |
| 01/09/2002 | EP1170374A1 Method for preperation of microprojectiles for efficient delivery of biologicals using a particle gun |
| 01/09/2002 | EP1169644A1 Method to type prion proteins |
| 01/09/2002 | EP1169641A1 Proteome mining |
| 01/09/2002 | EP1169483A2 VARIATION IN DRUG RESPONSE RELATED TO POLYMORPHISMS IN $g(b) 2?- ADRENERGIC RECEPTOR |
| 01/09/2002 | EP1169482A1 Genotypic classification method |
| 01/09/2002 | EP1169481A1 Method of identifying toxic agents using differential gene expression |
| 01/09/2002 | EP1169479A2 Methods for detecting nucleic acids indicative of cancer |
| 01/09/2002 | EP1169478A2 Method for identifying organisms by means of comparative genetic analysis and primers and hybridisation probes for carrying out this method |
| 01/09/2002 | EP1169477A1 ISOLATION OF cDNA ENCODING FOR SECRETED OR MEMBRANAL PROTEINS |
| 01/09/2002 | EP1169476A1 Detection of melanoma |
| 01/09/2002 | EP1169475A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy |
| 01/09/2002 | EP1169474A1 Olignucleotide array and methods of use |
| 01/09/2002 | EP1169473A1 High sensitivity phage display biomolecule detection |
| 01/09/2002 | EP1169472A2 Compound assay using nematodes |
| 01/09/2002 | EP1169470A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |
| 01/09/2002 | EP1169469A1 Human colon cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1169459A1 Dsp-9 dual-specificity map kinase phosphatase |
| 01/09/2002 | EP1169455A1 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 01/09/2002 | EP1169451A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 01/09/2002 | EP1169448A1 Tumor necrosis factor homologs and nucleic acids encoding the same |
| 01/09/2002 | EP1169447A1 Genes and expression products from hematopoietic cells |
| 01/09/2002 | EP1169446A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 01/09/2002 | EP1169445A2 Human proteins and polynucleotides encoding them |
| 01/09/2002 | EP1169444A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2002 | EP1169443A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21 |